Yield on Cost (YOC): 0.21%
The yield on cost (YOC) is 0.21%.
GEHC Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
0.21%
Yield on Cost for GEHC
GEHC now pays $0.14 per share a year. Measured against the price it actually traded at back then, a long-term holder is earning:
| If you bought | Price then | Yield on cost today |
|---|---|---|
| 3 years ago(2023-06-26) | $77.80 | 0.18% |
| 1 year ago(2025-06-26) | $74.86 | 0.19% |
| Buying today(at $65.76) | $65.76 | 0.21% |
Yield on Cost Calculator
Try your own purchase price, dividend and growth rate for GE HealthCare Technologies Inc. (GEHC).
Starting Yield
0.21%
Ending YOC
0.68%
Year 15 Dividend
$0.44
Cum. Dividends Recd.
$4.11
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $0.14 | — | 0.21% | $0.00 |
| Year 1 | $0.15 | +8.00% | 0.23% | $0.15 |
| Year 2 | $0.16 | +8.00% | 0.25% | $0.31 |
| Year 3 | $0.18 | +8.00% | 0.27% | $0.49 |
| Year 4 | $0.19 | +8.00% | 0.29% | $0.68 |
| Year 5 | $0.21 | +8.00% | 0.31% | $0.89 |
| Year 6 | $0.22 | +8.00% | 0.34% | $1.11 |
| Year 7 | $0.24 | +8.00% | 0.36% | $1.35 |
| Year 8 | $0.26 | +8.00% | 0.39% | $1.61 |
| Year 9 | $0.28 | +8.00% | 0.43% | $1.89 |
| Year 10 | $0.30 | +8.00% | 0.46% | $2.19 |
| Year 11 | $0.33 | +8.00% | 0.50% | $2.52 |
| Year 12 | $0.35 | +8.00% | 0.54% | $2.87 |
| Year 13 | $0.38 | +8.00% | 0.58% | $3.25 |
| Year 14 | $0.41 | +8.00% | 0.63% | $3.66 |
| Year 15 | $0.44 | +8.00% | 0.68% | $4.11 |
Yield on Cost (YOC) Formula & Definition
Yield on cost is the dividend yield measured against your original purchase price, not today's price. As a company raises its dividend, the yield on what you actually paid keeps rising even when the market yield holds steady.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Yield on Cost (YOC) FAQ
- What is the yield on cost (YOC) for GE HealthCare Technologies Inc. (GEHC)?
- The yield on cost (YOC) for GEHC stock is 0.21%.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Peter J. Arduini